|
A successful molecular farming system must be underpinned by sophisticated technology.
Our company has worldwide exclusive access to technology specifically developed for this purpose.
We call it INPACT (ie In-Plant Activation technology) and it forms the basis of Farmacule’s intellectual property assets.
|
Image courtesy of Queensland University of Technology, Plant Biotechnology Program
|
|
The
INPACT technology was initially developed by a team of molecular biologists
under Prof. James Dale’s lead at the Queensland University of Technology.
|
Farmacule has the exclusive worldwide licence to INPACT and Prof. Dale, in his role as Managing Director and Chief Scientific Officer at Farmacule, continues to drive the research program to develop new and existing applications of the technology.
INPACT has a number of unique qualities and is part of the ‘next generation’ of plant gene expression technology.
It allows Farmacule to insert a molecular switch into the basic operating machinery of a plant which can control the way proteins are produced.
Through INPACT’s application, genetically-enhanced plants can be produced which manufacture specific proteins in targeted areas such as leaves, roots and seeds.
The technology also allows Farmacule to turn the production of genes on and off in plants when required – either in response to specific external or internal influences.
Moreover, INPACT offers Farmacule the capability to increase the level of gene expression in plants which can be readily scaled up for high-value protein production.
All of these factors are vital to the establishment of a successful molecular farming industry in Australia and will be further demonstrated when Farmacule moves to small-scale production within the next two years.
|
